Christopher Robinson/LinkedIn
Oct 26, 2025, 08:36
Christopher Robinson: Aspirin Prophylaxis Did Not Reduce Preterm Preeclampsia
Christopher Robinson, Associate Professor of Maternal Fetal Medicine at the University of South Carolina, posted on LinkedIn:
”Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study.”
Title: Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study
Authors: Núria Mans-Gallart, Sara Carlhäll, Eric Hildebrand, Daniel Axelsson, Caroline Lilliecreutz
Read the full article here.
Stay informed with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy